Global Hypertrophic and Keloid Scar Treatment Market by Product (Topical, Injectable, Laser), by End Use (E-commerce, Clinics), by Scar Type (Keloid, Hypertrophic) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global hypertrophic and Keloid Scar Treatment Market was valued at USD4.8 billion in 2017. It is expected to grow 9.9% during the forecast period. This is due to a growing awareness about aesthetic appearance. This will likely lead to a rise in demand for procedures that enhance the esthetic appeal.
Scar treatment offers complete skin rejuvenation and enhances esthetic appeal. Women are the main consumers of esthetic products, and they have the highest demand. The market for hypertrophic and Keloid scar treatment has seen a rise in road accidents and burn victims.
According to the American Burn Association, more than 40,000 burn injury-related hospitalizations were recorded in 2016. This shows a rise in burn injuries worldwide. These injuries can cause hypertrophic scarring -- a common side effect. Surgery marks can also develop from road accidents that lead to surgery.
These factors and the subsequent rise in cosmetic procedures have fueled the demand for topical treatments. Laser therapies are faster and more effective than traditional treatments. They are also minimally invasive and can be used without pain, making them the most popular treatment option.
Scar Type Insights
The largest market share was held by the Keloid segment in 2017. It is expected to grow at the fastest rate over the forecast period. Keloid scars can be surgically removed, which is a better option than hypertrophic scars. They can be treated using topical treatments such as silicone gel sheets or laser therapies. Pressure therapy, and skin needling are all methods to reduce scarring.
Due to lower use of treatments to remove hypertrophic marks, the hypertrophic segment will likely experience sluggish growth in the future. Treatments include non-invasive techniques such as gels and creams or silicone sheets for minor injuries, and laser therapy in the case of severe injuries. In most cases, however, the treatment involves a combination of several therapies.
Product Insights
The market leader in terms of products was the topical segment in 2017. This is due to the increased demand for creams and silicone sheets as well as gels for the treatment of hypertrophic as well as keloid marks. These products are also easily accessible to consumers as Over the-the-Counter products (OTC), which is another reason for their high demand.
The fastest growing segment in the forecast is laser instruments. Laser treatments are painless and they will be the fastest growing. They also have many other benefits such as a shorter healing time and fewer adverse effects. Because they are quick and affordable, injectables dominated the market in 2017. Injectables have a longer-lasting effect than other treatments.
You can also find cryotherapy, compression therapy, radiotherapy and pressure therapy. Pressure garments speed up the healing process and decrease scarring. Cryotherapy is a treatment that uses cryoguns to treat scar tissue and reduce its size.
End-use Insights
Hospitals generated the highest revenue in 2017 based on end use. This is due to the wide variety of scar treatment options. Hospitals are preferable for emergency treatment, such as major accidents. They also provide care during recovery.
Because they offer specialized treatment, the clinics segment held a large market share in 2017. Patients visit hospitals first for treatment, then they go to specialty clinics. Clinics also often use the most technologically advanced products. These factors also contribute to the growth of the segment. The retail pharmacies/e-commerce segment is expected to show a significant growth over the forecast period as websites provide a wider range of products.
Regional Insights
North America was the market leader in 2017, and it is expected to continue its steady growth over the next few years. The market's growth is due to the high prevalence of skin-related disorders and burn injuries. The market growth is also supported by the availability and acceptance of advanced treatments such as lasers.
The U.S. government reimburses scar treatment for burn injuries. This is expected to have a positive effect on the local market. Europe saw a significant increase in the number and quality of plastic surgery units in 2017. This region is a highly lucrative market because of its favorable reimbursement policies.
Asia Pacific will see the fastest CAGR during the forecast period due to the availability of advanced products and the presence of many manufacturers in countries such as China. The market has seen a rise in demand for laser instruments, which are now available at lower prices in emerging markets. India, which has a high rate of burn injuries, has contributed greatly to the region's expansion.
Market Share insights for Hypertrophic and Keloid Scar Treatment
Smith & Nephew PLC, Enaltus, LLC, Merz, Inc., Lumenis, Sonoma Pharmaceuticals, Cynosure, Inc., Scar Heal, Inc., Molnlycke Health Care AB, Perrigo Company plc, NewMedical Technology, Inc., Suneva Medical, Inc., and Pacific World Corporation are some of the major market players.
To expand their businesses, major manufacturers have taken strategic initiatives such as product development and mergers and acquisitions. Merz North America, Inc., for example, announced in April 2017 the launch of Mederma Spezial, and Mederma Quick Dry Oil, which are both used to treat scarring.
Hypertrophic and Keloid Scar Treatment Market Report Scope
Report Attribute |
More Details |
2020 Market Size Value |
USD 6,321.0 Million |
Forecast Revenues in 2025 |
USD 10.163.0 Million |
Growth Rate |
CAGR of 9.9% between 2018 and 2025 |
Estimation base year |
2017 |
Historical data |
2014 - 2016 |
Forecast period |
2018 - 2025 |
Quantitative units |
From 2018 to 2025, revenue in USD millions and CAGR |
Report coverage |
Forecast revenue, company share, competitive landscape and growth factors and trends |
Segments covered |
Type, product, end-use, and region of scar |
Regional scope |
North America; Europe; Asia Pacific, Latin America; MEA |
Country coverage |
U.S.; Canada; Germany; U.K.; Japan; China; India; Brazil; Mexico; South Africa |
Key companies profiled |
Smith & Nephew PLC, Enaltus, LLC, Merz, Inc., Lumenis, Sonoma Pharmaceuticals, Cynosure, Inc., Scar Heal, Inc., Molnlycke Health Care AB, Perrigo Company plc, NewMedical Technology, Inc., Suneva Medical, Inc., Pacific World Corporation |
The scope of customization |
With purchase, you get free report customization (equivalent to up to 8 analysts working day) You can add or modify country, region and segment scope. |
Prices and purchase options |
You can get customized purchase options that meet your research needs. Explore your purchase options |
The Report Covers Certain Segments
This report predicts revenue growth and volume growth at the global, regional and country level. It also provides analysis of industry trends for each sub-segment from 2014 through 2025. Grand View Research has divided the global hypertrophic and keloid scar treatment market by scar type, product, end-use, region, and country.
-
Scar Type Outlook (Revenue USD Million, 2014-HT0_2025)
-
Hypertrophic
-
Keloid
-
-
Product Outlook (Revenue USD Million, 2014-2025)
-
Topical Products
-
Silicone Sheets
-
Creams
-
Gels
-
Other
-
-
Laser products
-
Pulse-dyed
-
CO 2
-
Other
-
-
Injectable
-
Other
-
-
End-Use Outlook (Revenue USD Million, 2014-2025)
-
Hospitals
-
Clinics
-
Retail Pharmacies/E-commerce
-
-
Regional Outlook (Revenue USD Million, 2014-2025)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
Germany
-
U.K.
-
-
Asia Pacific
-
Japan
-
China
-
India
-
-
Latin America
-
Brazil
-
Mexico
-
-
MEA
-
South Africa
-
-
These are the most frequently asked questions about this report
What is the market size for hypertrophic and Keloid scar treatment?b. Global hypertrophic and Keloid Scar Treatment Market Size was USD 5,765.1 Million in 2019. It is expected to grow to USD 6,321.0 Million in 2020.
What market growth is there for hypertrophic and Keloid Scar Treatment?b. Global hypertrophic and Keloid Scar Treatment Market is expected to grow at a compound annual rate of 9.9% between 2018-2025, to reach USD 10,163.0 Million by 2025.
Which market segment had the largest market share for hypertrophic and/or keloid scar treatments?b. With a 35.2% share in 2019, North America was the dominant market for hypertrophic and Keloid scar treatment. This can be attributed to the high incidence of burn injuries, skin disorders, and trauma.
What are the major players in the hypertrophic and Keloid Scar Treatment Market?b. Smith & Nephew PLC, Enaltus, LLC, Merz, Inc., Lumenis, Sonoma Pharmaceuticals, Cynosure, Inc., Scar Heal, Inc., Molnlycke Health Care AB, Perrigo Company plc, NewMedical Technology, Inc., Suneva Medical, Inc., and Pacific World Corporation are some of the key players in the hypertrophic scar treatment market.
What are the driving factors for the hypertrophic scar and keloid scar market?b. The market growth is being driven by a rise in demand for esthetics and the increase in burn cases and technologically advanced products.
Up Market Research published a new report titled “Hypertrophic and Keloid Scar Treatment Market research report which is segmented by Product (Topical, Injectable, Laser), by End Use (E-commerce, Clinics), by Scar Type (Keloid, Hypertrophic), By Players/Companies Inc; and Pacific World Corporation, Inc; Scar Heal, Inc; Suneva Medical, LLC; Merz, Inc; Lumenis; Sonoma Pharmaceuticals; Cynosure, Inc; M¶lnlycke Health Care AB; Perrigo Company plc; NewMedical Technology, Smith & Nephew PLC; Enaltus”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
Report Attributes | Report Details |
Report Title | Hypertrophic and Keloid Scar Treatment Market Research Report |
By Product | Topical, Injectable, Laser |
By End Use | E-commerce, Clinics |
By Scar Type | Keloid, Hypertrophic |
By Companies | Inc; and Pacific World Corporation, Inc; Scar Heal, Inc; Suneva Medical, LLC; Merz, Inc; Lumenis; Sonoma Pharmaceuticals; Cynosure, Inc; M¶lnlycke Health Care AB; Perrigo Company plc; NewMedical Technology, Smith & Nephew PLC; Enaltus |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 240 |
Number of Tables & Figures | 168 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Hypertrophic and Keloid Scar Treatment Market Report Segments:
The market is segmented by Product (Topical, Injectable, Laser), by End Use (E-commerce, Clinics), by Scar Type (Keloid, Hypertrophic).
Hypertrophic and Keloid Scar Treatment Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hypertrophic and Keloid Scar Treatment Market
Overview of the regional outlook of the Hypertrophic and Keloid Scar Treatment Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Hypertrophic and Keloid Scar Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Hypertrophic and Keloid Scar Treatment Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Topical
2. Injectable
3. Laser
7. By End Use:1. E-commerce
2. Clinics
8. By Scar Type:1. Keloid
2. Hypertrophic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hypertrophic and Keloid Scar Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Hypertrophic and Keloid Scar Treatment Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hypertrophic and Keloid Scar Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hypertrophic and Keloid Scar Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hypertrophic and Keloid Scar Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hypertrophic and Keloid Scar Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hypertrophic and Keloid Scar Treatment Market Size & Forecast, 2018-2028
4.5.1 Hypertrophic and Keloid Scar Treatment Market Size and Y-o-Y Growth
4.5.2 Hypertrophic and Keloid Scar Treatment Market Absolute $ Opportunity
Chapter 5 Global Hypertrophic and Keloid Scar Treatment Market Analysis and Forecast by Product
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Product
5.1.2 Basis Point Share (BPS) Analysis by Product
5.1.3 Absolute $ Opportunity Assessment by Product
5.2 Hypertrophic and Keloid Scar Treatment Market Size Forecast by Product
5.2.1 Topical
5.2.2 Injectable
5.2.3 Laser
5.3 Market Attractiveness Analysis by Product
Chapter 6 Global Hypertrophic and Keloid Scar Treatment Market Analysis and Forecast by End Use
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by End Use
6.1.2 Basis Point Share (BPS) Analysis by End Use
6.1.3 Absolute $ Opportunity Assessment by End Use
6.2 Hypertrophic and Keloid Scar Treatment Market Size Forecast by End Use
6.2.1 E-commerce
6.2.2 Clinics
6.3 Market Attractiveness Analysis by End Use
Chapter 7 Global Hypertrophic and Keloid Scar Treatment Market Analysis and Forecast by Scar Type
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Scar Type
7.1.2 Basis Point Share (BPS) Analysis by Scar Type
7.1.3 Absolute $ Opportunity Assessment by Scar Type
7.2 Hypertrophic and Keloid Scar Treatment Market Size Forecast by Scar Type
7.2.1 Keloid
7.2.2 Hypertrophic
7.3 Market Attractiveness Analysis by Scar Type
Chapter 8 Global Hypertrophic and Keloid Scar Treatment Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Hypertrophic and Keloid Scar Treatment Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Hypertrophic and Keloid Scar Treatment Analysis and Forecast
10.1 Introduction
10.2 North America Hypertrophic and Keloid Scar Treatment Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Hypertrophic and Keloid Scar Treatment Market Size Forecast by Product
10.6.1 Topical
10.6.2 Injectable
10.6.3 Laser
10.7 Basis Point Share (BPS) Analysis by Product
10.8 Absolute $ Opportunity Assessment by Product
10.9 Market Attractiveness Analysis by Product
10.10 North America Hypertrophic and Keloid Scar Treatment Market Size Forecast by End Use
10.10.1 E-commerce
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by End Use
10.12 Absolute $ Opportunity Assessment by End Use
10.13 Market Attractiveness Analysis by End Use
10.14 North America Hypertrophic and Keloid Scar Treatment Market Size Forecast by Scar Type
10.14.1 Keloid
10.14.2 Hypertrophic
10.15 Basis Point Share (BPS) Analysis by Scar Type
10.16 Absolute $ Opportunity Assessment by Scar Type
10.17 Market Attractiveness Analysis by Scar Type
Chapter 11 Europe Hypertrophic and Keloid Scar Treatment Analysis and Forecast
11.1 Introduction
11.2 Europe Hypertrophic and Keloid Scar Treatment Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Hypertrophic and Keloid Scar Treatment Market Size Forecast by Product
11.6.1 Topical
11.6.2 Injectable
11.6.3 Laser
11.7 Basis Point Share (BPS) Analysis by Product
11.8 Absolute $ Opportunity Assessment by Product
11.9 Market Attractiveness Analysis by Product
11.10 Europe Hypertrophic and Keloid Scar Treatment Market Size Forecast by End Use
11.10.1 E-commerce
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by End Use
11.12 Absolute $ Opportunity Assessment by End Use
11.13 Market Attractiveness Analysis by End Use
11.14 Europe Hypertrophic and Keloid Scar Treatment Market Size Forecast by Scar Type
11.14.1 Keloid
11.14.2 Hypertrophic
11.15 Basis Point Share (BPS) Analysis by Scar Type
11.16 Absolute $ Opportunity Assessment by Scar Type
11.17 Market Attractiveness Analysis by Scar Type
Chapter 12 Asia Pacific Hypertrophic and Keloid Scar Treatment Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Hypertrophic and Keloid Scar Treatment Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Hypertrophic and Keloid Scar Treatment Market Size Forecast by Product
12.6.1 Topical
12.6.2 Injectable
12.6.3 Laser
12.7 Basis Point Share (BPS) Analysis by Product
12.8 Absolute $ Opportunity Assessment by Product
12.9 Market Attractiveness Analysis by Product
12.10 Asia Pacific Hypertrophic and Keloid Scar Treatment Market Size Forecast by End Use
12.10.1 E-commerce
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by End Use
12.12 Absolute $ Opportunity Assessment by End Use
12.13 Market Attractiveness Analysis by End Use
12.14 Asia Pacific Hypertrophic and Keloid Scar Treatment Market Size Forecast by Scar Type
12.14.1 Keloid
12.14.2 Hypertrophic
12.15 Basis Point Share (BPS) Analysis by Scar Type
12.16 Absolute $ Opportunity Assessment by Scar Type
12.17 Market Attractiveness Analysis by Scar Type
Chapter 13 Latin America Hypertrophic and Keloid Scar Treatment Analysis and Forecast
13.1 Introduction
13.2 Latin America Hypertrophic and Keloid Scar Treatment Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Hypertrophic and Keloid Scar Treatment Market Size Forecast by Product
13.6.1 Topical
13.6.2 Injectable
13.6.3 Laser
13.7 Basis Point Share (BPS) Analysis by Product
13.8 Absolute $ Opportunity Assessment by Product
13.9 Market Attractiveness Analysis by Product
13.10 Latin America Hypertrophic and Keloid Scar Treatment Market Size Forecast by End Use
13.10.1 E-commerce
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by End Use
13.12 Absolute $ Opportunity Assessment by End Use
13.13 Market Attractiveness Analysis by End Use
13.14 Latin America Hypertrophic and Keloid Scar Treatment Market Size Forecast by Scar Type
13.14.1 Keloid
13.14.2 Hypertrophic
13.15 Basis Point Share (BPS) Analysis by Scar Type
13.16 Absolute $ Opportunity Assessment by Scar Type
13.17 Market Attractiveness Analysis by Scar Type
Chapter 14 Middle East & Africa (MEA) Hypertrophic and Keloid Scar Treatment Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Hypertrophic and Keloid Scar Treatment Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Hypertrophic and Keloid Scar Treatment Market Size Forecast by Product
14.6.1 Topical
14.6.2 Injectable
14.6.3 Laser
14.7 Basis Point Share (BPS) Analysis by Product
14.8 Absolute $ Opportunity Assessment by Product
14.9 Market Attractiveness Analysis by Product
14.10 Middle East & Africa (MEA) Hypertrophic and Keloid Scar Treatment Market Size Forecast by End Use
14.10.1 E-commerce
14.10.2 Clinics
14.11 Basis Point Share (BPS) Analysis by End Use
14.12 Absolute $ Opportunity Assessment by End Use
14.13 Market Attractiveness Analysis by End Use
14.14 Middle East & Africa (MEA) Hypertrophic and Keloid Scar Treatment Market Size Forecast by Scar Type
14.14.1 Keloid
14.14.2 Hypertrophic
14.15 Basis Point Share (BPS) Analysis by Scar Type
14.16 Absolute $ Opportunity Assessment by Scar Type
14.17 Market Attractiveness Analysis by Scar Type
Chapter 15 Competition Landscape
15.1 Hypertrophic and Keloid Scar Treatment Market: Competitive Dashboard
15.2 Global Hypertrophic and Keloid Scar Treatment Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 Inc; and Pacific World Corporation
15.3.2 Inc; Scar Heal
15.3.3 Inc; Suneva Medical
15.3.4 LLC; Merz
15.3.5 Inc; Lumenis; Sonoma Pharmaceuticals; Cynosure
15.3.6 Inc; M¶lnlycke Health Care AB; Perrigo Company plc; NewMedical Technology
15.3.7 Smith & Nephew PLC; Enaltus